We are live on !
Find out more
FORA Capital Portfolio holdings
AUM
$1.46B
Turnover
69.98%
1-Year Est. Return
64.79%
This Fund
S&P 500
This Quarter Est. Return
+29.06%
1 Year Est. Return
+64.79%
3 Year Est. Return
+161.8%
5 Year Est. Return
+205.45%
10 Year Est. Return
–
AUM
$1.46B
AUM Growth
+$91.8M
(+6.7%)
Cap. Flow
+$34.5M
Cap. Flow % of AUM
Cap. Flow %
2.37%
Top 10 Holdings %
Top 10 Hldgs %
16.73%
Holding
583
New
170
Increased
97
Reduced
78
Closed
238
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$39.8M |
| 2 |
Boston Scientific
BSX
|
+$20.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$20.6M |
| 4 |
Ross Stores
ROST
|
+$19.7M |
| 5 |
Cisco
CSCO
|
+$19.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$23.2M |
| 2 |
Verizon
VZ
|
+$22M |
| 3 |
Microsoft
MSFT
|
+$19.8M |
| 4 |
Cummins
CMI
|
+$19.7M |
| 5 |
Caterpillar
CAT
|
+$19.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.44% |
| 2 | Industrials | 11.01% |
| 3 | Financials | 10.69% |
| 4 | Consumer Discretionary | 9.75% |
| 5 | Healthcare | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Acuity Brands
AYI
$9.5B
| $1.65M | 0.11% |
4,369
-7,950
| -65% | -$2.36M |
2026 Q1
1 quarter
|
|
177
Affiliated Managers Group
AMG
$10.2B
| $1.61M | 0.11% |
4,760
-9,118
| -66% | -$2.83M |
2026 Q1
1 quarter
|
|
178
Hilton Grand Vacations
HGV
$2.88B
| $1.59M | 0.11% |
+30,377
| New | +$1.47M |
2026 Q2
0 quarters
|
|
179
Alnylam Pharmaceuticals
ALNY
$30.4B
| $1.57M | 0.11% |
5,209
+738
| +17% | +$223K |
2025 Q3
3 quarters
|
|
180
Abivax
ABVX
$7.87B
| $1.57M | 0.11% |
11,758
-1,428
| -11% | -$162K |
2025 Q4
2 quarters
|
|
181
Roivant Sciences
ROIV
$27.1B
| $1.56M | 0.11% |
44,129
-9,280
| -17% | -$274K |
2025 Q4
2 quarters
|
|
182
Axsome Therapeutics
AXSM
$8.18B
| $1.56M | 0.11% |
6,364
+4,914
| +339% | +$1.07M |
2025 Q4
2 quarters
|
|
183
Travere Therapeutics
TVTX
$4.94B
| $1.55M | 0.11% |
+27,289
| New | +$1.21M |
2026 Q2
0 quarters
|
|
184
Chefs' Warehouse
CHEF
$4.38B
| $1.52M | 0.1% |
+15,800
| New | +$1.22M |
2026 Q2
0 quarters
|
|
185
Elastic
ESTC
$10.3B
| $1.49M | 0.1% |
26,078
-4,108
| -14% | -$220K |
2026 Q1
1 quarter
|
|
186
Hasbro
HAS
$16.5B
| $1.48M | 0.1% |
+17,943
| New | +$1.61M |
2026 Q2
0 quarters
|
|
187
NuScale Power
SMR
$2.21B
| $1.48M | 0.1% |
147,269
+135,395
| +1,140% | +$1.53M |
2025 Q4
2 quarters
|
|
188
Liquidia Corp
LQDA
$3.55B
| $1.47M | 0.1% |
+18,457
| New | +$989K |
2026 Q2
0 quarters
|
|
189
Ralph Lauren
RL
$22.8B
| $1.45M | 0.1% |
+3,619
| New | +$1.35M |
2026 Q2
0 quarters
|
|
190
CleanSpark
CLSK
$2.09B
| $1.45M | 0.1% |
+99,690
| New | +$1.41M |
2026 Q2
0 quarters
|
|
191
Victoria's Secret
VSXY
$7.05B
| $1.44M | 0.1% |
17,267
-27,511
| -61% | -$1.65M |
2025 Q4
2 quarters
|
|
192
Domino's
DPZ
$10.5B
| $1.43M | 0.1% |
+4,823
| New | +$1.59M |
2026 Q2
0 quarters
|
|
193
Praxis Precision Medicines
PRAX
$7.23B
| $1.41M | 0.1% |
4,205
+793
| +23% | +$251K |
2026 Q1
1 quarter
|
|
194
Aptiv
APTV
$9.1B
| $1.39M | 0.1% |
22,701
+18,368
| +424% | +$1.12M |
2026 Q1
1 quarter
|
|
195
Viking Holdings
VIK
$38B
| $1.39M | 0.1% |
+13,235
| New | +$1.15M |
2026 Q2
0 quarters
|
|
196
MYR Group
MYRG
$3.97B
| $1.35M | 0.09% |
+2,688
| New | +$1.1M |
2026 Q2
0 quarters
|
|
197
Regeneron Pharmaceuticals
REGN
$84.3B
| $1.34M | 0.09% |
+2,147
| New | +$1.46M |
2026 Q2
0 quarters
|
|
198
Jazz Pharmaceuticals
JAZZ
$13.9B
| $1.3M | 0.09% |
+5,408
| New | +$1.18M |
2026 Q2
0 quarters
|
|
199
IES Holdings
IESC
$9.36B
| $1.3M | 0.09% |
+3,550
| New | +$1.15M |
2026 Q2
0 quarters
|
|
200
Exelixis
EXEL
$16.2B
| $1.26M | 0.09% |
+23,067
| New | +$1.12M |
2026 Q2
0 quarters
|
|
Similar funds
FORA Capital's Q2 2026 Portfolio in Review
As of Q2 2026, FORA Capital held 583 positions worth $1.46B, up 6.7% from $1.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
FORA Capital's Q2 2026 filing shows 170 new, 97 increased, 78 reduced and 238 closed positions. Its largest new stake was Intuit: 114,377 shares worth $29.8M. The largest sale was Oracle, an estimated $23.2M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 28% a quarter earlier, followed by Industrials and Financials.
- FORA Capital's largest Q2 2026 buy was Intuit: 114,377 shares worth $29.8M.
- FORA Capital added most to Boston Scientific in Q2 2026, an estimated $20.9M increase.
- FORA Capital's biggest Q2 2026 reduction was Microsoft, cutting an estimated $19.8M.
- FORA Capital fully exited Oracle in Q2 2026, selling an estimated $23.2M.
- FORA Capital's ten largest holdings make up 17% of its $1.46B portfolio in Q2 2026.
- FORA Capital opened 170 new positions and closed 238 in Q2 2026.
- FORA Capital's portfolio value rose 6.7% quarter-over-quarter to $1.46B.
Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.